Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
Determining the effect of fasting diet (5: 2 and 8.16 diets) in comparison with the control group on some metabolic factors, inflammation, steatosis and liver fibrosis in patients with non-alcoholic fatty liver
Determining the effect of fasting diet (5: 2 and 8.16 diets) combined with a Low-Sugar Diet in comparison with the control group on some metabolic factors, inflammation, steatosis and liver fibrosis in patients with non-alcoholic fatty liver
Determining the effect of fasting diet (5: 2 and 8.16 diets) combined with a Low-Sugar Diet in comparison with the control group on some metabolic factors, inflammation, steatosis and liver fibrosis in patients with non-alcoholic fatty liver
تعیین تاثیر رژیم شبه روزه داری) رژیم شبه فستینگ 5:2 و رژیم شبه فستینگ 16/8) در مقایسه با گروه کنترل بر روی برخی از فاکتورهای متابولیکی، التهابی، استئاتوز و فیبروز کبدی در بیماران مبتلا به کبدچرب غیرالکلی
تعیین تاثیر رژیم شبه روزه داری) رژیم شبه فستینگ 5:2 و رژیم شبه فستینگ 16/8) همراه با رژیم محدودیت قندهای ساده در مقایسه با گروه کنترل بر روی برخی از فاکتورهای متابولیکی، التهابی، استئاتوز و فیبروز کبدی در بیماران مبتلا به کبدچرب غیرالکلی
تعیین تاثیر رژیم شبه روزه داری) رژیم شبه فستینگ 5:2 و رژیم شبه فستینگ 16/8) همراه با رژیم محدودیت قندهای ساده در مقایسه با گروه کنترل بر روی برخی از فاکتورهای متابولیکی، التهابی، استئاتوز و فیبروز کبدی در بیماران مبتلا به کبدچرب غیرالکلی
1- Control
2-fasting diet (5 /2)
3- intermittent-fasting diet 8/16
1- Control
2-fasting diet (5 /2) combined with a Low-Sugar Diet
3- intermittent-fasting diet 8/16 combined with a Low-Sugar Diet
1- Control 2-fasting diet (5 /2) combined with a Low-Sugar Diet 3- intermittent-fasting diet 8/16 combined with a Low-Sugar Diet
1-کنترل 2- رژیم شبه فستینگ ( 5/2 ) 3- رژیم شبه فستینگ 16/8
1-کنترل 2- رژیم شبه فستینگ ( 5/2 ) همراه با محدودیت قندهای ساده 3- رژیم شبه فستینگ16/8 همراه با محدودیت قندهای ساده
1-کنترل 2- رژیم شبه فستینگ ( 5/2 ) همراه با محدودیت قندهای ساده 3- رژیم شبه فستینگ 16فستینگ16/8 همراه با محدودیت قندهای ساده
General information
empty
Update the title and variables
Update the title and variables
empty
به روز رسانی عنوان و متغییرها
به روز رسانی عنوان و متغییرها
Evaluation of the effects of Fasting Mimicking Diet (FMD) on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD)
Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
بررسی تاثیر رژیم شبه روزه داری بر شاخصهای لیپیدی، قندی، التهابی و بافتی کبد چرب غیر الکلی
بررسی تاثیر رژیم شبه روزه داری همراه با محدودت قندهای ساده بر شاخصهای لیپیدی، قندی، التهابی و بافتی کبد چرب غیر الکلی: یک کارآزمایی بالینی
بررسی تاثیر رژیم شبه روزه داری همراه با محدودت قندهای ساده بر شاخصهای لیپیدی، قندی، التهابی و بافتی کبد چرب غیر الکلی: یک کارآزمایی بالینی
Evaluation of the effects of Fasting Mimicking Diet (FMD) on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
بررسی تاثیر رژیم شبه روزه داری بر شاخصهای لیپیدی، قندی، التهابی و بافتی کبد چرب غیر الکلی: یک کارآزمایی بالینی
بررسی تاثیر رژیم شبه روزه داری همراه با محدودت قندهای ساده بر شاخصهای لیپیدی، قندی، التهابی و بافتی کبد چرب غیر الکلی: یک کارآزمایی بالینی
بررسی تاثیر رژیم شبه روزه داری همراه با محدودت قندهای ساده بر شاخصهای لیپیدی، قندی، التهابی و بافتی کبد چرب غیر الکلی: یک کارآزمایی بالینی
Secondary outcomes
#1
IGF1
CK-18
IGF1CK-18
فاکتور رشد شبه انسولینی 1
سایتوکراتین 18
فاکتور رشد شبه انسولینی 1سایتوکراتین 18
#2
empty
TAC
TAC
empty
ظرفیت آنتی اکسیدانی کل
ظرفیت آنتی اکسیدانی کل
empty
At the first and 12th week of the study
At the first and 12th week of the study
empty
در هفته اول و دوازدهم مطالعه
در هفته اول و دوازدهم مطالعه
empty
ELISA
ELISA
empty
الایزا
الایزا
Intervention groups
#1
Intervention group: fasting diet (5 days of normal diet and two consecutive days with 75% calorie restriction and permission to consume 25% of calories per person at a specific time, for example 12 to 16 am because it is easier to tolerate fasting)
Intervention group: fasting diet (5 days of normal diet and two consecutive days with 75% calorie restriction and permission to consume 25% of calories per person at a specific time, for example 12 to 16 am because it is easier to tolerate fasting) combined with a Low-Sugar Diet
Intervention group: fasting diet (5 days of normal diet and two consecutive days with 75% calorie restriction and permission to consume 25% of calories per person at a specific time, for example 12 to 16 am because it is easier to tolerate fasting) combined with a Low-Sugar Diet
گروه مداخله: رژیم شبه فستینگ ( 5 روز رژیم معمول فرد و دو روز پی در پی با محدودیت 75 درصدی مصرف کالری و اجازه مصرف 25 درصد کالری فرد درساعتی مشخص به طور مثال 12 تا16 به دلیل راحت تر بودن تحمل فستینگ)
گروه مداخله: رژیم شبه فستینگ ( 5 روز رژیم معمول فرد و دو روز پی در پی با محدودیت 75 درصدی مصرف کالری و اجازه مصرف 25 درصد کالری فرد درساعتی مشخص به طور مثال 12 تا16 به دلیل راحت تر بودن تحمل فستینگ) همراه با محدودیت قندهای ساده
گروه مداخله: رژیم شبه فستینگ ( 5 روز رژیم معمول فرد و دو روز پی در پی با محدودیت 75 درصدی مصرف کالری و اجازه مصرف 25 درصد کالری فرد درساعتی مشخص به طور مثال 12 تا16 به دلیل راحت تر بودن تحمل فستینگ) همراه با محدودیت قندهای ساده
#2
Intervention group: fasting diet 8/16: 16 hours a day in fasting diet for example 8 nights to 12 noon and 8 hours normal diet
Intervention group combined with a Low-Sugar Diet : fasting diet 8/16: 16 hours a day in fasting diet for example 8 nights to 12 noon and 8 hours normal diet Combined with a Low-Sugar Diet
Intervention group combined with a Low-Sugar Diet : fasting diet 8/16: 16 hours a day in fasting diet for example 8 nights to 12 noon and 8 hours normal diet Combined with a Low-Sugar Diet
گروه مداخله: رژیم شبه فستینگ 16/8: 16 ساعت در شبانه روز در حالت شبه فستینگ به طور مثال 8 شب تا 12ظهر و 8 ساعت رژیم معمول
گروه مداخله: رژیم شبه فستینگ 16/ 8 همراه با محدودیت قندهای ساده: 16 ساعت در شبانه روز در حالت شبه فستینگ به طور مثال 8 شب تا 12ظهر و 8 ساعت رژیم معمول همراه با محدودیت قندهای ساده
گروه مداخله: رژیم شبه فستینگ 16/8 همراه با محدودیت قندهای ساده: 16 ساعت در شبانه روز در حالت شبه فستینگ به طور مثال 8 شب تا 12ظهر و 8 ساعت رژیم معمول همراه با محدودیت قندهای ساده
Recruitment centers
#1
Name of recruitment center - English: Gastroenterology and Liver Clinic of Taleghani Hospital
Name of recruitment center - Persian: کلینیک گوارش و کبد بیمارستان طالقانی
Full name of responsible person - English: Azita Hekmatdoost
Full name of responsible person - Persian: آزیتا حکمت دوست
Street address - English: Tabnak St. Velenjak Region, Chamran High Way, Tehran, Iran
Street address - Persian: تهران - بزرگراه شهید چمران خیابان یــمن - خیابان شهید اعــرابی
City - English: تهران
City - Persian: تهران
Province: Tehran
Country: Iran (Islamic Republic of)
Postal code: 1985717413
Phone: +98 21 2235 7484
Fax:
Email: a_hekmat2000@yahoo.com
Web page address:
Name of recruitment center - English: Gastroenterology and Liver Clinic of Taleghani Hospital
Name of recruitment center - Persian: کلینیک گوارش و کبد بیمارستان طالقانی
Full name of responsible person - English: Azita Hekmatdoost
Full name of responsible person - Persian: آزیتا حکمت دوست
Street address - English: Tabnak St. Velenjak Region, Chamran High Way, Tehran, Iran
Street address - Persian: تهران - بزرگراه شهید چمران خیابان یــمن - خیابان شهید اعــرابی
City - English: Tehran
City - Persian: تهران
Province: Tehran
Country: Iran (Islamic Republic of)
Postal code: 1985717413
Phone: +98 21 2235 7484
Fax:
Email: a_hekmat2000@yahoo.com
Web page address:
Name of recruitment center - English: Gastroenterology and Liver Clinic of Taleghani Hospital Name of recruitment center - Persian: کلینیک گوارش و کبد بیمارستان طالقانی Full name of responsible person - English: Azita Hekmatdoost Full name of responsible person - Persian: آزیتا حکمت دوست Street address - English: Tabnak St. Velenjak Region, Chamran High Way, Tehran, Iran Street address - Persian: تهران - بزرگراه شهید چمران خیابان یــمن - خیابان شهید اعــرابی City - English: تهرانTehran City - Persian: تهران Province: Tehran Country: Iran (Islamic Republic of) Postal code: 1985717413 Phone: +98 21 2235 7484 Fax: Email: a_hekmat2000@yahoo.com Web page address:
Protocol summary
Study aim
Determining the effect of fasting diet (5: 2 and 8.16 diets) combined with a Low-Sugar Diet in comparison with the control group on some metabolic factors, inflammation, steatosis and liver fibrosis in patients with non-alcoholic fatty liver
Design
Randomized clinical trials with control groups, parallel groups are performed on 63 patients
Settings and conduct
In this study, adults with non-alcoholic fatty liver disease referred to liver clinic of Taleghani hospital, who have the criteria to enter the study, if they desire to participate in this research fill out general and activity questionnaires and anthropometric indicators are collected. At the beginning and end of the study, fibroscan and blood tests are performed to evaluate the indicators
Participants/Inclusion and exclusion criteria
People who desire to participate in the study; age 18-50 years; BMI above 25 who have evidence of non-alcoholic steatohepatitis in ultrasound or fibroscan; no history of alcohol consumption or alcohol consumption less than 10 grams per day in women and less than 20 grams per day in men; absence of other chronic and acute liver diseases and disorders, biliary tract disease, autoimmune diseases, cancer and hereditary disorders affecting Liver status and liver cirrhosis, lack of pregnancy or lactation in women; no use of hepatotoxic drugs are included in the study. If they do not want to continue studying or using hepatotoxic drugs during the study or non-compliance with the diet, they are excluded.
Intervention groups
1- Control
2-fasting diet (5 /2) combined with a Low-Sugar Diet
3- intermittent-fasting diet 8/16 combined with a Low-Sugar Diet
Shahid Beheshti University of Medical Sciences, National Institute of Nutrition Research
Country
Iran (Islamic Republic of)
Phone
+98 21 2293 0824
Email address
hekmat@sina.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2020-09-22, 1399/07/01
Expected recruitment end date
2021-09-23, 1400/07/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
Public title
Evaluation of the effects of Fasting Mimicking Diet (FMD) Combined with a Low-Sugar Diet on lipid profile, glycemic, inflammatory and histologic indices in Non-Alcoholic Fatty Liver (NAFLD): a randomized control trial
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
General desire to participate in the study
Age 50-30 years
- Has evidence of non-alcoholic steatohepatitis and CAP score more than 263
Body mass index (BMI) ≥ 25kg / m2
No history of alcohol consumption
Lack of other diseases and chronic and acute liver disorders (hepatitis B, C, etc.), biliary disease, known autoimmune diseases and hereditary disorders affecting the condition of the liver (iron, copper and ... )
No pregnancy or breastfeeding in women
Do not take hepatotoxic drugs such as phenytoin, amoxifen and lithium
Do not take antibiotics for more than a week during or before the study period
Do not consume Milk thistle(Silybum marianum)
Lack of chronic inflammatory disease
No history of cancer
Lack of treatment with anti-inflammatory drugs
Lack of recent weight loss diet
Blood pressure less than 90/160 mmHg
No kidney disease (GFR greater than 60 or creatinine between 7-1.4)
No weight loss of more than 8% in the last 6 months
Do not use weight loss drugs (chemical drugs and effective herbal products)
Exclusion criteria:
Changes in medications (lipid-lowering drugs, blood sugar control drugs, and blood pressure medications) during the study period
Lack of adherence to the diet given to patients
Take supplements or substances that change the individual effect of the diet during the intervention.
Age
From 18 years old to 50 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
75
Randomization (investigator's opinion)
Randomized
Randomization description
The first step is to create a random sequence number. For this purpose, we will use a random number generator on Stattrek (https://stattrek.com/statistics/random-number-generator.aspx) for 75 numbers range from 1 to 3 (for example: 2 1 3 1 2 1 2 1 1 3 3 3 3 2 2 3 2 3 1 1 2 2 3 3 1 2 2..............).Then, we will specify the numbers to the groups for example, 1 will be assigned to the intervention group one (fasting diet 2/5), the numbers 2 to the intervention group two (fasting diet 8/16), the numbers 3 to the control group. Each number will represent a group according to the defined numbers. With this method, we will have a specific sequence of 75 codes of 1, 2, 3 , which shows the first to seventy-fifth people who are going to be entered in the study in each group. We write the codes on a piece of paper and put them in an envelope to use during sampling. Thus, after reviewing the inclusion criteria and if the participants desire, we will enter each person included in the study according to our predetermined list.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of the National Institute of Nutritional Research and Food Industry
Street address
No. 7, West Arghavan Ave., Farahzadi Blvd., Qods Town
City
Tehran
Province
Tehran
Postal code
1981619573
Approval date
2020-11-14, 1399/08/24
Ethics committee reference number
IR.SBMU.NNFTRI.REC.1399.019
Health conditions studied
1
Description of health condition studied
Nonalcoholic fatty liver disease
ICD-10 code
K75.81
ICD-10 code description
Nonalcoholic steatohepatitis (NASH)
Primary outcomes
1
Description
Hepatic steatosis, Liver fibrosis
Timepoint
At the first and at the 12th week of the study
Method of measurement
fibroscan
Secondary outcomes
1
Description
Weight
Timepoint
At the first and 12th week of the study
Method of measurement
Scale
2
Description
BMI
Timepoint
At the first and 12th week of the study
Method of measurement
Calculate
3
Description
Waist to hip ratio
Timepoint
At the first and 12th week of the study
Method of measurement
Calculate
4
Description
liver enzymes (AST,ALT,GGT)
Timepoint
At the first and 12th week of the study
Method of measurement
Enzymatic method
5
Description
lipid profile (TG,Total cholesterol,LDL-C,HDL-C)
Timepoint
At the first and 12th week of the study
Method of measurement
Enzymatic method
6
Description
FBS
Timepoint
At the first and 12th week of the study
Method of measurement
Enzymatic method
7
Description
Insulin
Timepoint
At the first and 12th week of the study
Method of measurement
Radioimmunoassay
8
Description
hs-CRP
Timepoint
At the first and 12th week of the study
Method of measurement
ELISA
9
Description
CK-18
Timepoint
At the first and 12th week of the study
Method of measurement
ELISA
10
Description
HOMA-IR
Timepoint
At the first and 12th week of the study
Method of measurement
Calculate
11
Description
TAC
Timepoint
At the first and 12th week of the study
Method of measurement
ELISA
Intervention groups
1
Description
Control group: Dietary recommendations
Category
Lifestyle
2
Description
Intervention group: fasting diet (5 days of normal diet and two consecutive days with 75% calorie restriction and permission to consume 25% of calories per person at a specific time, for example 12 to 16 am because it is easier to tolerate fasting) combined with a Low-Sugar Diet
Category
Lifestyle
3
Description
Intervention group combined with a Low-Sugar Diet : fasting diet 8/16: 16 hours a day in fasting diet for example 8 nights to 12 noon and 8 hours normal diet Combined with a Low-Sugar Diet
Category
Lifestyle
Recruitment centers
1
Recruitment center
Name of recruitment center
Gastroenterology and Liver Clinic of Taleghani Hospital
Full name of responsible person
Azita Hekmatdoost
Street address
Tabnak St. Velenjak Region, Chamran High Way, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1985717413
Phone
+98 21 2235 7484
Email
a_hekmat2000@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Azita Hekmatdoost
Street address
No. 7, West Arghavan Ave., Farahzadi Blvd., Qods Town
City
Tehran
Province
Tehran
Postal code
1981619573
Phone
+98 21 2235 7483
Email
a_hekmat2000@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Azita Hekmatdoost
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 7, West Arghavan Ave., Farahzadi Blvd., Qods Town
City
tehran
Province
Tehran
Postal code
1981619573
Phone
+98 21 2235 7483
Email
a_hekmat2000@yahoo.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Azita Hekmatdoost
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 7, West Arghavan Ave., Farahzadi Blvd., Qods Town
City
Tehran
Province
Tehran
Postal code
1981619573
Phone
+98 21 2235 7483
Email
a_hekmat2000@yahoo.com
Person responsible for updating data
Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Azita Hekmatdoost
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 7, West Arghavan Ave., Farahzadi Blvd., Qods Town
City
Tehran
Province
Tehran
Postal code
1981619573
Phone
+98 21 2235 7483
Email
a_hekmat2000@yahoo.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available